Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinib.

Gángó A, Alpár D, Galik B, Marosvári D, Kiss R, Fésüs V, Aczél D, Eyüpoglu E, Nagy N, Nagy Á, Krizsán S, Reiniger L, Farkas P, Kozma A, Ádám E, Tasnády S, Réti M, Matolcsy A, Gyenesei A, Mátrai Z, Bödör C.

Int J Cancer. 2019 Jun 10. doi: 10.1002/ijc.32502. [Epub ahead of print]

PMID:
31180577
2.

Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies.

Trojnar E, Józsi M, Szabó Z, Réti M, Farkas P, Kelen K, Reusz GS, Szabó AJ, Garam N, Mikes B, Sinkovits G, Mező B, Csuka D, Prohászka Z.

Front Immunol. 2019 Feb 25;10:240. doi: 10.3389/fimmu.2019.00240. eCollection 2019.

3.

[Change in paradigm in the treatment of pediatric acquired bone marrow failure syndromes in Hungary].

Kállay K, Csomor J, Ádám E, Bödör C, Kassa C, Simon R, Kovács G, Péter G, Ottóffy G, Bartyik K, Kiss C, Masát P, Réti M, Tóth B, Kriván G.

Orv Hetil. 2018 Oct;159(42):1710-1719. doi: 10.1556/650.2018.31171. Hungarian.

PMID:
30334483
4.

Concentration and Subclass Distribution of Anti-ADAMTS13 IgG Autoantibodies in Different Stages of Acquired Idiopathic Thrombotic Thrombocytopenic Purpura.

Sinkovits G, Szilágyi Á, Farkas P, Inotai D, Szilvási A, Tordai A, Rázsó K, Réti M, Prohászka Z.

Front Immunol. 2018 Jul 16;9:1646. doi: 10.3389/fimmu.2018.01646. eCollection 2018.

5.

Early Experience With CliniMACS Prodigy CCS (IFN-gamma) System in Selection of Virus-specific T Cells From Third-party Donors for Pediatric Patients With Severe Viral Infections After Hematopoietic Stem Cell Transplantation.

Kállay K, Kassa C, Réti M, Karászi É, Sinkó J, Goda V, Stréhn A, Csordás K, Horváth O, Szederjesi A, Tasnády S, Hardi A, Kriván G.

J Immunother. 2018 Apr;41(3):158-163. doi: 10.1097/CJI.0000000000000197.

PMID:
29239916
6.

[Allogeneic hematopoietic stem cell transplantation in Hungary].

Bátai Á, Reményi P, Réti M, Barta A, Gopcsa L, Lengyel L, Torbágyi É, Csukly Z, Karászi É, Tordai A, Andrikovics H, Balassa K, Tasnády S, Masszi T.

Orv Hetil. 2017 Feb;158(8):291-297. doi: 10.1556/650.2017.30648. Hungarian.

PMID:
28218567
7.

The role of human leukocyte antigen DRB1-DQB1 haplotypes in the susceptibility to acquired idiopathic thrombotic thrombocytopenic purpura.

Sinkovits G, Szilágyi Á, Farkas P, Inotai D, Szilvási A, Tordai A, Rázsó K, Réti M, Prohászka Z.

Hum Immunol. 2017 Feb;78(2):80-87. doi: 10.1016/j.humimm.2016.11.005. Epub 2016 Nov 17.

PMID:
27866840
8.

Decreased Neutrophil Extracellular Trap Degradation in Shiga Toxin-Associated Haemolytic Uraemic Syndrome.

Leffler J, Prohászka Z, Mikes B, Sinkovits G, Ciacma K, Farkas P, Réti M, Kelen K, Reusz GS, Szabó AJ, Martin M, Blom AM.

J Innate Immun. 2017;9(1):12-21. doi: 10.1159/000450609. Epub 2016 Oct 27.

9.

Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies.

Farkas P, Csuka D, Mikes B, Sinkovits G, Réti M, Németh E, Rácz K, Madách K, Gergely M, Demeter J, Prohászka Z.

Immunobiology. 2017 Feb;222(2):119-127. doi: 10.1016/j.imbio.2016.10.014. Epub 2016 Oct 18.

PMID:
27771173
10.

Corrigendum to "Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura" [Thromb. Res. 133 (2014) 616-621].

Mikes B, Sinkovits G, Farkas P, Csuka D, Schlammadinger Á, Rázsó K, Demeter J, Domján G, Réti M, Prohászka Z.

Thromb Res. 2016 May;141:145. doi: 10.1016/j.thromres.2016.03.023. Epub 2016 Apr 2. No abstract available.

PMID:
27143029
11.

Early Versus Delayed Autologous Stem Cell Transplantation and Interferon Maintenance in Multiple Myeloma: Single-Center Experience of 18 Years.

Remenyi P, Varga G, Mikala G, Reti M, Gopcsa L, Batai A, Csukly Z, Lengyel L, Torbagyi E, Barta A, Fabian J, Levai D, Szombath G, Andrikovics H, Masszi T.

Transplant Proc. 2016 Jan-Feb;48(1):177-84. doi: 10.1016/j.transproceed.2015.12.031.

PMID:
26915865
12.

Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.

Szarvas N, Szilágyi Á, Csuka D, Takács B, Rusai K, Müller T, Arbeiter K, Réti M, Haris Á, Wagner L, Török S, Kelen K, Szabó AJ, Reusz GS, Morgan BP, Prohászka Z.

Mol Immunol. 2016 Mar;71:10-22. doi: 10.1016/j.molimm.2016.01.003. Epub 2016 Jan 27.

PMID:
26826462
13.

Carboxiterminal pro-endothelin-1 as an endothelial cell biomarker in thrombotic thrombocytopenic purpura.

Mikes B, Sinkovits G, Farkas P, Csuka D, Rázsó K, Réti M, Radványi G, Demeter J, Prohászka Z.

Thromb Haemost. 2016 May 2;115(5):1034-43. doi: 10.1160/TH15-07-0564. Epub 2016 Jan 14.

PMID:
26763086
14.

The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Balassa K, Andrikovics H, Remenyi P, Batai A, Bors A, Kiss KP, Szilvasi A, Rajczy K, Inotai D, Gopcsa L, Lengyel L, Barta A, Reti M, Tordai A, Masszi T.

Bone Marrow Transplant. 2015 Oct;50(10):1321-5. doi: 10.1038/bmt.2015.161. Epub 2015 Jul 6.

PMID:
26146809
15.

Peripheral blood stem cell mobilization and engraftment after autologous stem cell transplantation with biosimilar rhG-CSF.

Reményi P, Gopcsa L, Marton I, Réti M, Mikala G, Pető M, Barta A, Bátai A, Farkas Z, Borbényi Z, Csukly Z, Bodó I, Fábián J, Király A, Lengyel L, Piukovics K, Torbágyi E, Masszi T.

Adv Ther. 2014 Apr;31(4):451-60. doi: 10.1007/s12325-014-0114-z. Epub 2014 Apr 1.

PMID:
24687301
16.

Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura.

Mikes B, Sinkovits G, Farkas P, Csuka D, Schlammadinger A, Rázsó K, Demeter J, Domján G, Réti M, Prohászka Z.

Thromb Res. 2014 Apr;133(4):616-21. doi: 10.1016/j.thromres.2014.01.034. Epub 2014 Feb 1.

PMID:
24548690
17.

Complement activation in thrombotic thrombocytopenic purpura.

Réti M, Farkas P, Csuka D, Rázsó K, Schlammadinger Á, Udvardy ML, Madách K, Domján G, Bereczki C, Reusz GS, Szabó AJ, Prohászka Z.

J Thromb Haemost. 2012 May;10(5):791-8. doi: 10.1111/j.1538-7836.2012.04674.x.

18.

Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it's not too late.

Basak GW, Mikala G, Koristek Z, Jaksic O, Basic-Kinda S, Cegledi A, Reti M, Masszi T, Mayer J, Giebel S, Hübel K, Labar B, Wiktor-Jedrzejczak W.

Leuk Lymphoma. 2011 Sep;52(9):1711-9. doi: 10.3109/10428194.2011.578312. Epub 2011 Jun 12.

PMID:
21663509
19.

Diagnosis and classification of hemolytic uremic syndrome: the Hungarian experience.

Reusz GS, Szabó AJ, Réti M, Györke Z, Szilágyi Á, Farkas P, Prohászka Z.

Transplant Proc. 2011 May;43(4):1247-9. doi: 10.1016/j.transproceed.2011.03.071.

PMID:
21620101
20.

Anti-TNF-alpha-induced anti-phospholipid syndrome manifested as necrotizing vasculitis.

Vereckei E, Kriván G, Réti M, Szodoray P, Poór G, Kiss E.

Scand J Rheumatol. 2010 Mar;39(2):175-7. doi: 10.3109/03009740902832753. No abstract available.

PMID:
20337548
21.

ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.

Peyvandi F, Lavoretano S, Palla R, Feys HB, Vanhoorelbeke K, Battaglioli T, Valsecchi C, Canciani MT, Fabris F, Zver S, Réti M, Mikovic D, Karimi M, Giuffrida G, Laurenti L, Mannucci PM.

Haematologica. 2008 Feb;93(2):232-9. doi: 10.3324/haematol.11739. Epub 2008 Jan 26.

22.

Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy.

Vertesaljai M, Piroth Z, Fontos G, Andreka G, Font G, Szantho G, Lueff S, Reti M, Masszi T, Ablonczy L, Juhasz ED, Simor T, Turner MS, Andreka P.

Heart Fail Rev. 2008 Jun;13(2):227-44. Epub 2007 Aug 1. Review.

PMID:
17668319
23.

Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation.

Kriván G, Sinkó J, Nagy IZ, Goda V, Reményi P, Bátai A, Lueff S, Kapás B, Réti M, Tremmel A, Masszi T.

Acta Biomed. 2006;77 Suppl 2:17-21.

PMID:
16918062
24.

Alloimmune and autoimmune background in recurrent pregnancy loss - successful immunotherapy by intravenous immunoglobulin.

Kotlan B, Padanyi A, Batorfi J, Fulop V, Szigetvari I, Rajczy K, Penzes M, Gyodi E, Reti M, Petranyi G.

Am J Reprod Immunol. 2006 May;55(5):331-40.

PMID:
16635207
25.

[Experiences with the first, Hungarian autologous bone marrow cell transplantation in acute myocardial infarction].

Vértesaljai M, Piróth Z, Fontos G, Tóth A, Simor T, Lueff S, Reményi P, Réti M, Masszi T, Andréka P.

Orv Hetil. 2006 Jan 8;147(1):3-6. Hungarian.

PMID:
16519064
26.

[Stem cell therapy in cardiovascular diseases].

Vértesaljai M, Piróth Z, Fontos G, Andréka G, Font G, Szánthó G, Réti M, Masszi T, Andréka P.

Orv Hetil. 2005 Nov 20;146(47):2383-8. Review. Hungarian.

PMID:
16398150
27.

Ten-year remission of psoriasis after allogeneic but not autologous bone marrow transplantation.

Masszi T, Farkas A, Remenyi P, Lueff S, Batai A, Krivan G, Kemeny L, Dobozy A, Reti M.

Dermatology. 2006;212(1):88-9. No abstract available.

PMID:
16319484
28.

[Intravenous immunoglobulin treatment of recurrent spontaneous abortion with immunopathological background].

Bátorfi J, Kotlán B, Padányi A, Réti M, Gyódi E, Rajczy K, Miklós K, Németh J, Melicher F, Vályi-Nagy I, Petrányi G, Fülöp V.

Orv Hetil. 2005 Nov 6;146(45):2297-302. Hungarian.

PMID:
16304808
29.

Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemia.

Barta A, Dénes R, Masszi T, Reményi P, Bátai A, Torbágyi E, Sipos A, Lengyel L, Jakab K, Gyódi E, Réti M, Földi J, Páldi-Haris P, Avalos M, Pálóczi K, Fekete S, Török J, Hoffer I, Jakab J, Váradi G, Kelemen E, Petrányi G.

Acta Haematol. 2001;105(2):64-70.

PMID:
11408706
30.

High anti-paternal cytotoxic T-lymphocyte precursor frequencies in women with unexplained recurrent spontaneous abortions.

Kotlan B, Fülöp V, Padányi A, Szigetvári I, Réti M, Gyódi E, Fehér E, Petrányi G.

Hum Reprod. 2001 Jun;16(6):1278-85.

PMID:
11387306
31.

HLA-G gene polymorphism in the normal population and in recurrent spontaneous abortion in Hungary.

Pénzes M, Rajczy K, Gyódi E, Réti M, Fehér E, Petrányi G.

Transplant Proc. 1999 Jun;31(4):1832-3. No abstract available.

PMID:
10371965
32.

Autologous stem cell transplantation for malignant lymphomas.

Reményi P, Masszi T, Kriván G, Goda V, Réti M.

Bone Marrow Transplant. 1998 Dec;22 Suppl 4:S104-6.

PMID:
9916651
33.

Bone marrow transplantation in non-malignant disorders.

Kriván G, Timár L, Goda V, Réti M, Reményi P, Masszi T.

Bone Marrow Transplant. 1998 Dec;22 Suppl 4:S80-3.

PMID:
9916644
34.

Allogeneic bone marrow transplantation for acute leukemia in adults.

Masszi T, Reményi P, Kriván G, Goda V, Réti M.

Bone Marrow Transplant. 1998 Dec;22 Suppl 4:S77-9.

PMID:
9916643
35.

Humoral and cell-mediated factors involved in the suppressive regulation induced by special blood derivatives and their clinical relevance.

Padányi A, Horuzsko A, Gyódi E, Réti M, Pócsik E, Kotlán B, Perner F, Petrányi G.

Transplant Proc. 1998 Dec;30(8):3967-71. No abstract available.

PMID:
9865264
36.

[A new radiation-free conditioning in bone marrow transplantation and dibromo-mannitol therapy in chronic myeloid leukemia].

Kelemen E, Dénes R, Barta A, Masszi T, Reményi P, Pálóczi K, Bátai A, Torbágyo E, Sipos A, Lengyel L, Jakab K, Gyódi E, Réti M, Földi J, Páldi-Haris P, Manuel A, Fekete S, Török J, Hoffer I, Jakab J, Váradi G, Petrányi G.

Orv Hetil. 1998 Aug 23;139(34):2003-1; discussion 2011-2. Review. Hungarian.

PMID:
9745304
37.

Do black elderly Medicare patients receive fewer services? An analysis of procedure use for selected patient conditions.

Lee AJ, Baker CS, Gehlbach S, Hosmer DW, Reti M.

Med Care Res Rev. 1998 Sep;55(3):314-33. No abstract available.

PMID:
9727301
38.

Long-term related kidney graft survival in high-risk patients after monitored donor-specific transfusion protocol.

Padányi A, Horuzsko A, Gyódi E, Réti M, Perner F, Petrányi GG.

Transpl Int. 1998;11 Suppl 1:S110-4.

PMID:
9664958
39.

Immunologic consequences of blood transfusion and their clinical manifestations.

Petrányi GG, Réti M, Harsányi V, Szabó J.

Int Arch Allergy Immunol. 1997 Dec;114(4):303-15. Review.

PMID:
9414132
40.

Medicare treatment differences for blacks and whites.

Lee AJ, Gehlbach S, Hosmer, Reti M, Baker CS.

Med Care. 1997 Dec;35(12):1173-89.

PMID:
9413306
41.

[Intrauterine management of Rh-alloimmunization].

Intödy Z, Hajdu K, Réti M, Gombos S, Mészáros J, Vörös J, Jakab J, Hoffer I, Doszpod J.

Orv Hetil. 1996 Mar 31;137(13):675-9. Hungarian.

PMID:
8649747
42.

Blast colony forming cells in umbilical cord blood: frequency and correlation to other haemopoietic progenitors.

Gidáli J, Fehér I, Harsányi V, Réti M.

Haematologia (Budap). 1996;28(1):27-32.

PMID:
9283901
43.

Immunophenotypic and functional characteristics of haemopoietic cells from human cord blood.

Milosevits J, Pócsik E, Schmidt B, Reményi P, Intödi ZS, Réti M, Bátai A, Illés P, Mihalik R, Petrányi GG, et al.

Scand J Immunol. 1995 Oct;42(4):493-500.

PMID:
7569784
44.

The polymorphic human TLX-B/CD46/MCP system and its implications in transplantation and reproduction.

Petrányi G, Padányi A, Szelényi J, Sármay G, Gyódi E, Fülöp V, Kassai M, Illés P, Réti M, Szigetvári I, et al.

Eur J Immunogenet. 1995 Apr;22(2):147-61.

PMID:
7605772
45.

Differences in non-MHC restricted cytotoxic activities of human peripheral blood lymphocytes after transfusion with allogeneic leukocytes or platelets possessing class I and/or class II MHC molecules.

Pócsik E, Mihalik R, Réti M, Gyódi E, Pálóczi K, Mayer K, Kassai M, Herold M, Huber C, Petrányi GG, et al.

Immunobiology. 1990 Dec;182(1):22-31.

PMID:
1983002
46.

Functional and immunogenetic characterization of FcR-blocking antibody.

Padányi A, Gyódi E, Sarmay G, Réti M, Mayer K, Kassai M, Petrányi GG.

Immunol Lett. 1990 Nov;26(2):131-7.

PMID:
2269483
47.

Non-cytotoxic blocking antibodies and suppressor cells induced by donor-specific transfusions in healthy volunteers and potential kidney transplant recipients.

Horuzsko A, Gyódi E, Réti M, Onody K, Perner F, Kassay M, Petrányi GG.

Immunol Lett. 1990 Nov;26(2):127-30.

PMID:
2148542
48.
49.

Activation of lymphocytes after platelet allotransfusion possessing only class I MHC product.

Pócsik E, Mihalik R, Gyódi E, Réti M, Pálóczi K, Petrányi GG, Benczúr M.

Clin Exp Immunol. 1990 Oct;82(1):102-7.

50.

Supplemental Content

Support Center